<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/nport" xmlns:com="http://www.sec.gov/edgar/common" xmlns:ncom="http://www.sec.gov/edgar/nportcommon" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sec.gov/edgar/nport eis_NPORT_Filer.xsd">
  <headerData>
    <submissionType>NPORT-P</submissionType>
    <isConfidential>false</isConfidential>
    <filerInfo>

      <filer>
        <issuerCredentials>
          <cik>0001559109</cik>
          <ccc>XXXXXXXX</ccc>
        </issuerCredentials>
      </filer>


      <seriesClassInfo>
        <seriesId>S000047353</seriesId>
        <classId>C000148681</classId>
      </seriesClassInfo>

    </filerInfo>
  </headerData>
  <formData>
    <genInfo>
      <regName>ETFis Series Trust I</regName>
      <regFileNumber>811-22819</regFileNumber>
      <regCik>0001559109</regCik>
      <regLei>5493002CWTVLBPSYFT98</regLei>
      <regStreet1>1301 Avenue of the Americas</regStreet1>
      <regStreet2>14th Floor</regStreet2>
      <regCity>New York</regCity>
      <regStateConditional regCountry="US" regState="US-NY"/>
      <regZipOrPostalCode>10019</regZipOrPostalCode>
      <regPhone>1-888-383-0553</regPhone>
      <seriesName>Virtus Biotech Clinical Trials Etf</seriesName>
      <seriesId>S000047353</seriesId>
      <seriesLei>549300YTBZ16PIXEKJ82</seriesLei>
      <repPdEnd>2026-10-31</repPdEnd>
      <repPdDate>2026-07-31</repPdDate>
      <isFinalFiling>N</isFinalFiling>
    </genInfo>
    <fundInfo>
      <totAssets>48033382.80</totAssets>
      <totLiabs>1640801.76</totLiabs>
      <netAssets>46392581.04</netAssets>
      <assetsAttrMiscSec>0.00000000</assetsAttrMiscSec>
      <assetsInvested>0.00000000</assetsInvested>
      <amtPayOneYrBanksBorr>0.00000000</amtPayOneYrBanksBorr>
      <amtPayOneYrCtrldComp>0.00000000</amtPayOneYrCtrldComp>
      <amtPayOneYrOthAffil>0.00000000</amtPayOneYrOthAffil>
      <amtPayOneYrOther>0.00000000</amtPayOneYrOther>
      <amtPayAftOneYrBanksBorr>0.00000000</amtPayAftOneYrBanksBorr>
      <amtPayAftOneYrCtrldComp>0.00000000</amtPayAftOneYrCtrldComp>
      <amtPayAftOneYrOthAffil>0.00000000</amtPayAftOneYrOthAffil>
      <amtPayAftOneYrOther>0.00000000</amtPayAftOneYrOther>
      <delayDeliv>0.00000000</delayDeliv>
      <standByCommit>0.00000000</standByCommit>
      <liquidPref>0.00000000</liquidPref>
      <cshNotRptdInCorD>87172.27000000</cshNotRptdInCorD>
      <borrowers>
        <borrower aggrVal="291678.20000000" lei="549300KUN9K9K32C6D97" name="BNP Paribas Prime Brokerage Intl Ltd"/>
        <borrower aggrVal="3474523.92000000" lei="AC28XWWI3WIBK2824319" name="Barclays Capital Inc."/>
        <borrower aggrVal="88775.13000000" lei="549300KNQS43Y7TO3X67" name="CLEAR STREET LLC"/>
        <borrower aggrVal="621863.76000000" lei="MBNUM2BPBDO7JBLYG310" name="Citigroup Global Markets Inc."/>
        <borrower aggrVal="549361.64000000" lei="FOR8UP27PHTHYVLBNG30" name="Goldman, Sachs &amp; Co. LLC"/>
        <borrower aggrVal="10044.00000000" lei="MP6I5ZYZBEU3UXPYFY54" name="HSBC BANK PLC"/>
        <borrower aggrVal="339570.00000000" lei="ZBUT11V806EZRVTWT807" name="J.P. Morgan Securities LLC"/>
        <borrower aggrVal="2613814.26703400" lei="58PU97L1C0WSRCWADL48" name="Jefferies LLC"/>
        <borrower aggrVal="329234.08000000" lei="9R7GPTSO7KV3UQJZQ078" name="Morgan Stanley &amp; Co. LLC"/>
        <borrower aggrVal="8470.00000000" lei="549300BLWPABP1VNME36" name="Scotia Capital (USA) INC"/>
        <borrower aggrVal="26296.27000000" lei="549300CSX55MXZ47EI78" name="WEDBUSH SECURITIES INC"/>
      </borrowers>
      <aggregateCondition isNonCashCollateral="Y">
        <aggregateInfos>
          <aggregateInfo amt="7413654.84711721" collatrl="7169552.22377522">
            <invstCat>UST</invstCat>
          </aggregateInfo>
        </aggregateInfos>
      </aggregateCondition>
      <returnInfo>
        <monthlyTotReturns>
          <monthlyTotReturn classId="C000148681" rtn1="1.60650000" rtn2="18.04010000" rtn3="-7.29930000"/>
        </monthlyTotReturns>
        <monthlyReturnCats>
          <commodityContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </commodityContracts>
          <creditContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </creditContracts>
          <equityContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </equityContracts>
          <foreignExchgContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </foreignExchgContracts>
          <interestRtContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </interestRtContracts>
          <otherContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </otherContracts>
        </monthlyReturnCats>
        <othMon1 netRealizedGain="1058135.76000000" netUnrealizedAppr="-709077.23000000"/>
        <othMon2 netRealizedGain="1164200.67000000" netUnrealizedAppr="6347542.29000000"/>
        <othMon3 netRealizedGain="1818961.95000000" netUnrealizedAppr="-5616715.84000000"/>
      </returnInfo>
      <mon1Flow redemption="2140564.49000000" reinvestment="0.00000000" sales="9107523.34000000"/>
      <mon2Flow redemption="2076140.15000000" reinvestment="0.00000000" sales="0.00000000"/>
      <mon3Flow redemption="5053388.06000000" reinvestment="0.00000000" sales="5214319.93000000"/>



    </fundInfo>
    <invstOrSecs>
      <invstOrSec>
        <name>PROKIDNEY CORP</name>
        <lei>N/A</lei>
        <title>PROKIDNEY CORP SHS CL A</title>
        <cusip>74291D104</cusip>
        <identifiers>
          <isin value="US74291D1046"/>
          <ticker value="PROK"/>
        </identifiers>
        <balance>189520.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>291860.80000000</valUSD>
        <pctVal>0.629110934242</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="269444.56000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>INTELLIA THERAPEUTICS INC</name>
        <lei>5493002T5BCPE5DZC723</lei>
        <title>INTELLIA THERAPEUTICS INC COM</title>
        <cusip>45826J105</cusip>
        <identifiers>
          <isin value="US45826J1051"/>
          <ticker value="NTLA"/>
        </identifiers>
        <balance>25666.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>274112.88000000</valUSD>
        <pctVal>0.590854989860</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="274102.20000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VIR BIOTECHNOLOGY INC</name>
        <lei>N/A</lei>
        <title>VIR BIOTECHNOLOGY INC COM</title>
        <cusip>92764N102</cusip>
        <identifiers>
          <isin value="US92764N1028"/>
          <ticker value="VIR"/>
        </identifiers>
        <balance>36099.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>312617.34000000</valUSD>
        <pctVal>0.673852010368</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ANAPTYSBIO INC</name>
        <lei>529900HH4WQT03IG1A12</lei>
        <title>ANAPTYSBIO INC COM</title>
        <cusip>032724106</cusip>
        <identifiers>
          <isin value="US0327241065"/>
          <ticker value="ANAB"/>
        </identifiers>
        <balance>5543.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>295774.48000000</valUSD>
        <pctVal>0.637546938259</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="295721.12000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>DYNE THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>DYNE THERAPEUTICS INC COM</title>
        <cusip>26818M108</cusip>
        <identifiers>
          <isin value="US26818M1080"/>
          <ticker value="DYN"/>
        </identifiers>
        <balance>17087.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>430250.66000000</valUSD>
        <pctVal>0.927412638734</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>IMMUNOVANT INC</name>
        <lei>N/A</lei>
        <title>IMMUNOVANT INC COM</title>
        <cusip>45258J102</cusip>
        <identifiers>
          <isin value="US45258J1025"/>
          <ticker value="IMVT"/>
        </identifiers>
        <balance>9245.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>357041.90000000</valUSD>
        <pctVal>0.769609907437</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>KYMERA THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>KYMERA THERAPEUTICS INC COM</title>
        <cusip>501575104</cusip>
        <identifiers>
          <isin value="US5015751044"/>
          <ticker value="KYMR"/>
        </identifiers>
        <balance>3605.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>372757.00000000</valUSD>
        <pctVal>0.803484073625</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>IMMIX BIOPHARMA INC</name>
        <lei>N/A</lei>
        <title>IMMIX BIOPHARMA INC COM</title>
        <cusip>45258H106</cusip>
        <identifiers>
          <isin value="US45258H1068"/>
          <ticker value="IMMX"/>
        </identifiers>
        <balance>36782.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>306026.24000000</valUSD>
        <pctVal>0.659644781858</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>PRIME MEDICINE INC</name>
        <lei>N/A</lei>
        <title>PRIME MEDICINE INC COM</title>
        <cusip>74168J101</cusip>
        <identifiers>
          <isin value="US74168J1016"/>
          <ticker value="PRME"/>
        </identifiers>
        <balance>112004.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>327051.68000000</valUSD>
        <pctVal>0.704965476523</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="327048.76000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>NEWAMSTERDAM PHARMA COMPANY NV</name>
        <lei>984500B6549TF6E14D36</lei>
        <title>NEWAMSTERDAM PHARMA COMPANY NV ORDINARY SHARES</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="NL00150012L7"/>
          <ticker value="NAMS"/>
        </identifiers>
        <balance>10224.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>284124.96000000</valUSD>
        <pctVal>0.612436199130</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>

        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BICARA THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>BICARA THERAPEUTICS INC COM</title>
        <cusip>055477103</cusip>
        <identifiers>
          <isin value="US0554771032"/>
          <ticker value="BCAX"/>
        </identifiers>
        <balance>14331.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>388370.10000000</valUSD>
        <pctVal>0.837138377071</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MBX BIOSCIENCES INC</name>
        <lei>N/A</lei>
        <title>MBX BIOSCIENCES INC COM</title>
        <cusip>55287L101</cusip>
        <identifiers>
          <isin value="US55287L1017"/>
          <ticker value="MBX"/>
        </identifiers>
        <balance>8754.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>577151.22000000</valUSD>
        <pctVal>1.244059302288</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ADLAI NORTYE LTD</name>
        <lei>54930009TDXE4YQVKU60</lei>
        <title>ADLAI NORTYE LTD SPONSORED ADS</title>
        <cusip>00704R109</cusip>
        <identifiers>
          <isin value="US00704R1095"/>
          <ticker value="ANL"/>
        </identifiers>
        <balance>30117.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>391521.00000000</valUSD>
        <pctVal>0.843930195783</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>INVIVYD INC</name>
        <lei>N/A</lei>
        <title>INVIVYD INC COM</title>
        <cusip>00534A102</cusip>
        <identifiers>
          <isin value="US00534A1025"/>
          <ticker value="IVVD"/>
        </identifiers>
        <balance>403655.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>215955.43000000</valUSD>
        <pctVal>0.465495614080</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ACHIEVE LIFE SCIENCES INC</name>
        <lei>549300V82ZKZDTAU0A46</lei>
        <title>ACHIEVE LIFE SCIENCES INC COM</title>
        <cusip>004468500</cusip>
        <identifiers>
          <isin value="US0044685008"/>
          <ticker value="ACHV"/>
        </identifiers>
        <balance>56308.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>361497.36000000</valUSD>
        <pctVal>0.779213727488</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="361490.94000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ALLOGENE THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>ALLOGENE THERAPEUTICS INC COM</title>
        <cusip>019770106</cusip>
        <identifiers>
          <isin value="US0197701065"/>
          <ticker value="ALLO"/>
        </identifiers>
        <balance>163586.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>307541.68000000</valUSD>
        <pctVal>0.662911338635</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>REPLIMUNE GROUP INC</name>
        <lei>549300AY704NEIRC4K64</lei>
        <title>REPLIMUNE GROUP INC COM</title>
        <cusip>76029N106</cusip>
        <identifiers>
          <isin value="US76029N1063"/>
          <ticker value="REPL"/>
        </identifiers>
        <balance>35001.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>392011.20000000</valUSD>
        <pctVal>0.844986830247</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>DREYFUS GOVERNMENT CASH MANAGE</name>
        <lei>N/A</lei>
        <title>DREYFUS GOVERNMENT CASH MANAGE</title>
        <cusip>000000000</cusip>
        <identifiers>
          <ticker value="DGCXX"/>
          <other otherDesc="INTERNAL" value="BYM4G0625"/>
        </identifiers>
        <balance>1612819.22000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1612819.22000000</valUSD>
        <pctVal>3.476459347259</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="1612819.22000000" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>KODIAK SCIENCES INC</name>
        <lei>254900IXI5NI8C9OQE24</lei>
        <title>KODIAK SCIENCES INC COM</title>
        <cusip>50015M109</cusip>
        <identifiers>
          <isin value="US50015M1099"/>
          <ticker value="KOD"/>
        </identifiers>
        <balance>9125.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>379417.50000000</valUSD>
        <pctVal>0.817840895019</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>EYEPOINT INC</name>
        <lei>549300QE1RU34T50MR69</lei>
        <title>EYEPOINT INC COM NEW</title>
        <cusip>30233G209</cusip>
        <identifiers>
          <isin value="US30233G2093"/>
          <ticker value="EYPT"/>
        </identifiers>
        <balance>23853.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>292199.25000000</valUSD>
        <pctVal>0.629840468992</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>UPSTREAM BIO INC</name>
        <lei>N/A</lei>
        <title>UPSTREAM BIO INC COM</title>
        <cusip>91678A107</cusip>
        <identifiers>
          <isin value="US91678A1079"/>
          <ticker value="UPB"/>
        </identifiers>
        <balance>50952.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>321507.12000000</valUSD>
        <pctVal>0.693014082839</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ABCELLERA BIOLOGICS INC</name>
        <lei>9845000861BC95FF9F73</lei>
        <title>ABCELLERA BIOLOGICS INC COM</title>
        <cusip>00288U106</cusip>
        <identifiers>
          <isin value="CA00288U1066"/>
          <ticker value="ABCL"/>
        </identifiers>
        <balance>59315.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>338688.65000000</valUSD>
        <pctVal>0.730049163912</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="276523.88000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CLIMB BIO INC</name>
        <lei>N/A</lei>
        <title>CLIMB BIO INC COM</title>
        <cusip>28658R106</cusip>
        <identifiers>
          <isin value="US28658R1068"/>
          <ticker value="CLYM"/>
        </identifiers>
        <balance>27171.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>323334.90000000</valUSD>
        <pctVal>0.696953893815</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>COMPASS THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>COMPASS THERAPEUTICS INC COM</title>
        <cusip>20454B104</cusip>
        <identifiers>
          <isin value="US20454B1044"/>
          <ticker value="CMPX"/>
        </identifiers>
        <balance>153110.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>292440.10000000</valUSD>
        <pctVal>0.630359625276</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>TECTONIC THERAPEUTIC INC</name>
        <lei>N/A</lei>
        <title>TECTONIC THERAPEUTIC INC COM</title>
        <cusip>878972108</cusip>
        <identifiers>
          <isin value="US8789721086"/>
          <ticker value="TECX"/>
        </identifiers>
        <balance>10265.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>287727.95000000</valUSD>
        <pctVal>0.620202505551</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ORIC PHARMACEUTICALS INC</name>
        <lei>54930033FJRNEYBW0L25</lei>
        <title>ORIC PHARMACEUTICALS INC COM</title>
        <cusip>68622P109</cusip>
        <identifiers>
          <isin value="US68622P1093"/>
          <ticker value="ORIC"/>
        </identifiers>
        <balance>37585.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>416065.95000000</valUSD>
        <pctVal>0.896837254304</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="416054.88000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BICYCLE THERAPEUTICS PLC</name>
        <lei>213800XKUI6R7GKC3E43</lei>
        <title>BICYCLE THERAPEUTICS PLC SPONSORED ADS</title>
        <cusip>088786108</cusip>
        <identifiers>
          <isin value="US0887861088"/>
          <ticker value="BCYC"/>
        </identifiers>
        <balance>76743.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>296227.98000000</valUSD>
        <pctVal>0.638524465247</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SANA BIOTECHNOLOGY INC</name>
        <lei>N/A</lei>
        <title>SANA BIOTECHNOLOGY INC COM</title>
        <cusip>799566104</cusip>
        <identifiers>
          <isin value="US7995661045"/>
          <ticker value="SANA"/>
        </identifiers>
        <balance>115976.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>363004.88000000</valUSD>
        <pctVal>0.782463212570</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BIOAGE LABS INC</name>
        <lei>529900NG0C40250Z7875</lei>
        <title>BIOAGE LABS INC COM</title>
        <cusip>09077V100</cusip>
        <identifiers>
          <isin value="US09077V1008"/>
          <ticker value="BIOA"/>
        </identifiers>
        <balance>17229.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>155750.16000000</valUSD>
        <pctVal>0.335722127349</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>GENERATE BIOMEDICINES INC</name>
        <lei>N/A</lei>
        <title>GENERATE BIOMEDICINES INC COM SHS</title>
        <cusip>370920100</cusip>
        <identifiers>
          <isin value="US3709201004"/>
          <ticker value="GENB"/>
        </identifiers>
        <balance>25106.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>351484.00000000</valUSD>
        <pctVal>0.757629759156</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="351470.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>STOKE THERAPEUTICS INC</name>
        <lei>549300RD25SS2DIJHJ67</lei>
        <title>STOKE THERAPEUTICS INC COM</title>
        <cusip>86150R107</cusip>
        <identifiers>
          <isin value="US86150R1077"/>
          <ticker value="STOK"/>
        </identifiers>
        <balance>10423.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>300807.78000000</valUSD>
        <pctVal>0.648396302289</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VERADERMICS INC</name>
        <lei>N/A</lei>
        <title>VERADERMICS INC COMMON STOCK</title>
        <cusip>922967104</cusip>
        <identifiers>
          <isin value="US9229671048"/>
          <ticker value="MANE"/>
        </identifiers>
        <balance>3235.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>339675.00000000</valUSD>
        <pctVal>0.732175258167</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="339570.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ANNEXON INC</name>
        <lei>N/A</lei>
        <title>ANNEXON INC COM</title>
        <cusip>03589W102</cusip>
        <identifiers>
          <isin value="US03589W1027"/>
          <ticker value="ANNX"/>
        </identifiers>
        <balance>65989.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>336213.96000000</valUSD>
        <pctVal>0.724714927393</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ZENAS BIOPHARMA INC</name>
        <lei>N/A</lei>
        <title>ZENAS BIOPHARMA INC COM</title>
        <cusip>98937L105</cusip>
        <identifiers>
          <isin value="US98937L1052"/>
          <ticker value="ZBIO"/>
        </identifiers>
        <balance>15697.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>493513.68000000</valUSD>
        <pctVal>1.063777157762</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="493482.24000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VAXCYTE INC</name>
        <lei>254900M7NMHTGASX8D95</lei>
        <title>VAXCYTE INC COM</title>
        <cusip>92243G108</cusip>
        <identifiers>
          <isin value="US92243G1085"/>
          <ticker value="PCVX"/>
        </identifiers>
        <balance>6549.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>354169.92000000</valUSD>
        <pctVal>0.763419305545</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ORUKA THERAPEUTICS INC</name>
        <lei>529900TG7O4ESUDMGI54</lei>
        <title>ORUKA THERAPEUTICS INC COM</title>
        <cusip>687604108</cusip>
        <identifiers>
          <isin value="US6876041087"/>
          <ticker value="ORKA"/>
        </identifiers>
        <balance>4447.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>429179.97000000</valUSD>
        <pctVal>0.925104748170</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SAVARA INC</name>
        <lei>5493002JO0WM3YMJXG33</lei>
        <title>SAVARA INC COM</title>
        <cusip>805111101</cusip>
        <identifiers>
          <isin value="US8051111016"/>
          <ticker value="SVRA"/>
        </identifiers>
        <balance>59090.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>322631.40000000</valUSD>
        <pctVal>0.695437487562</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>IMMATICS NV</name>
        <lei>984500DC691EZ96AF394</lei>
        <title>IMMATICS NV SHS</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="NL0015285941"/>
          <ticker value="IMTX"/>
        </identifiers>
        <balance>33135.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>286949.10000000</valUSD>
        <pctVal>0.618523681087</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>

        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ARCUS BIOSCIENCES INC</name>
        <lei>N/A</lei>
        <title>ARCUS BIOSCIENCES INC COM</title>
        <cusip>03969F109</cusip>
        <identifiers>
          <isin value="US03969F1093"/>
          <ticker value="RCUS"/>
        </identifiers>
        <balance>13060.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>368161.40000000</valUSD>
        <pctVal>0.793578179413</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>STRUCTURE THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>STRUCTURE THERAPEUTICS INC SPONSORED ADS</title>
        <cusip>86366E106</cusip>
        <identifiers>
          <isin value="US86366E1064"/>
          <ticker value="GPCR"/>
        </identifiers>
        <balance>7240.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>347809.60000000</valUSD>
        <pctVal>0.749709527262</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="347761.56000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AKTIS ONCOLOGY INC</name>
        <lei>N/A</lei>
        <title>AKTIS ONCOLOGY INC COM</title>
        <cusip>01021M104</cusip>
        <identifiers>
          <isin value="US01021M1045"/>
          <ticker value="AKTS"/>
        </identifiers>
        <balance>14173.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>312798.11000000</valUSD>
        <pctVal>0.674241663188</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>EDGEWISE THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>EDGEWISE THERAPEUTICS INC COM</title>
        <cusip>28036F105</cusip>
        <identifiers>
          <isin value="US28036F1057"/>
          <ticker value="EWTX"/>
        </identifiers>
        <balance>8925.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>342987.75000000</valUSD>
        <pctVal>0.739315947315</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>APOGEE THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>APOGEE THERAPEUTICS INC COM</title>
        <cusip>03770N101</cusip>
        <identifiers>
          <isin value="US03770N1019"/>
          <ticker value="APGE"/>
        </identifiers>
        <balance>3519.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>471862.71000000</valUSD>
        <pctVal>1.017108122510</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>FIRST TRACKS BIOTHERAPEUTICS INC</name>
        <lei>529900CGIGKN4R5RO925</lei>
        <title>FIRST TRACKS BIOTHERAPEUTICS INC ORD SHS</title>
        <cusip>337185102</cusip>
        <identifiers>
          <isin value="US3371851029"/>
          <ticker value="TRAX"/>
        </identifiers>
        <balance>17620.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>775984.80000000</valUSD>
        <pctVal>1.672648476554</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MONTE ROSA THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>MONTE ROSA THERAPEUTICS INC COM</title>
        <cusip>61225M102</cusip>
        <identifiers>
          <isin value="US61225M1027"/>
          <ticker value="GLUE"/>
        </identifiers>
        <balance>17045.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>281583.40000000</valUSD>
        <pctVal>0.606957823185</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MAPLIGHT THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>MAPLIGHT THERAPEUTICS INC COM</title>
        <cusip>56565P103</cusip>
        <identifiers>
          <isin value="US56565P1030"/>
          <ticker value="MPLT"/>
        </identifiers>
        <balance>11201.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>145837.02000000</valUSD>
        <pctVal>0.314354184938</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BIOHAVEN LTD</name>
        <lei>N/A</lei>
        <title>BIOHAVEN LTD COM</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="VGG1110E1079"/>
          <ticker value="BHVN"/>
        </identifiers>
        <balance>27554.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>371979.00000000</valUSD>
        <pctVal>0.801807081350</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>VG</invCountry>

        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>PRAXIS PRECISION MEDICINES INC</name>
        <lei>N/A</lei>
        <title>PRAXIS PRECISION MEDICINES INC COM NEW</title>
        <cusip>74006W207</cusip>
        <identifiers>
          <isin value="US74006W2070"/>
          <ticker value="PRAX"/>
        </identifiers>
        <balance>1166.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>358929.78000000</valUSD>
        <pctVal>0.773679264989</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VOR BIOPHARMA INC</name>
        <lei>N/A</lei>
        <title>VOR BIOPHARMA INC COM NEW</title>
        <cusip>929033207</cusip>
        <identifiers>
          <isin value="US9290332074"/>
          <ticker value="VOR"/>
        </identifiers>
        <balance>21644.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>457770.60000000</valUSD>
        <pctVal>0.986732338960</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>REVOLUTION MEDICINES INC</name>
        <lei>549300JU3X0LBCQ65892</lei>
        <title>REVOLUTION MEDICINES INC COM</title>
        <cusip>76155X100</cusip>
        <identifiers>
          <isin value="US76155X1000"/>
          <ticker value="RVMD"/>
        </identifiers>
        <balance>2020.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>378810.60000000</valUSD>
        <pctVal>0.816532711713</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ALUMIS INC</name>
        <lei>N/A</lei>
        <title>ALUMIS INC COM</title>
        <cusip>022307102</cusip>
        <identifiers>
          <isin value="US0223071020"/>
          <ticker value="ALMS"/>
        </identifiers>
        <balance>12870.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>363577.50000000</valUSD>
        <pctVal>0.783697504750</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>JADE BIOSCIENCES INC</name>
        <lei>N/A</lei>
        <title>JADE BIOSCIENCES INC COM NEW</title>
        <cusip>008064206</cusip>
        <identifiers>
          <isin value="US0080642061"/>
          <ticker value="JBIO"/>
        </identifiers>
        <balance>20261.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>400154.75000000</valUSD>
        <pctVal>0.862540391221</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ARRIVENT BIOPHARMA INC</name>
        <lei>N/A</lei>
        <title>ARRIVENT BIOPHARMA INC COM</title>
        <cusip>04272N102</cusip>
        <identifiers>
          <isin value="US04272N1028"/>
          <ticker value="AVBP"/>
        </identifiers>
        <balance>10177.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>303478.14000000</valUSD>
        <pctVal>0.654152308832</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AVALO THERAPEUTICS INC</name>
        <lei>549300GPK6FPJ3X8SZ39</lei>
        <title>AVALO THERAPEUTICS INC COM NEW</title>
        <cusip>05338F306</cusip>
        <identifiers>
          <isin value="US05338F3064"/>
          <ticker value="AVTX"/>
        </identifiers>
        <balance>21058.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>384308.50000000</valUSD>
        <pctVal>0.828383528971</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>DISC MEDICINE INC</name>
        <lei>N/A</lei>
        <title>DISC MEDICINE INC COM</title>
        <cusip>254604101</cusip>
        <identifiers>
          <isin value="US2546041011"/>
          <ticker value="IRON"/>
        </identifiers>
        <balance>4571.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>351967.00000000</valUSD>
        <pctVal>0.758670873897</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CELCUITY INC</name>
        <lei>25490070W7UU7W2SEY87</lei>
        <title>CELCUITY INC COM</title>
        <cusip>15102K100</cusip>
        <identifiers>
          <isin value="US15102K1007"/>
          <ticker value="CELC"/>
        </identifiers>
        <balance>3510.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>303193.80000000</valUSD>
        <pctVal>0.653539409110</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>IMMUNOME INC</name>
        <lei>N/A</lei>
        <title>IMMUNOME INC COM</title>
        <cusip>45257U108</cusip>
        <identifiers>
          <isin value="US45257U1088"/>
          <ticker value="IMNM"/>
        </identifiers>
        <balance>16911.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>384894.36000000</valUSD>
        <pctVal>0.829646360197</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="20256.40000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BEAM THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>BEAM THERAPEUTICS INC COM</title>
        <cusip>07373V105</cusip>
        <identifiers>
          <isin value="US07373V1052"/>
          <ticker value="BEAM"/>
        </identifiers>
        <balance>10708.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>273268.16000000</valUSD>
        <pctVal>0.589034181487</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>EVOMMUNE INC</name>
        <lei>N/A</lei>
        <title>EVOMMUNE INC COM SHS</title>
        <cusip>30054Y107</cusip>
        <identifiers>
          <isin value="US30054Y1073"/>
          <ticker value="EVMN"/>
        </identifiers>
        <balance>15674.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>176332.50000000</valUSD>
        <pctVal>0.380087712403</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ENLIVEN THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>ENLIVEN THERAPEUTICS INC COM</title>
        <cusip>29337E102</cusip>
        <identifiers>
          <isin value="US29337E1029"/>
          <ticker value="ELVN"/>
        </identifiers>
        <balance>6738.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>369309.78000000</valUSD>
        <pctVal>0.796053532097</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ARBUTUS BIOPHARMA CORP</name>
        <lei>25490064CESONAUIAS23</lei>
        <title>ARBUTUS BIOPHARMA CORP COM</title>
        <cusip>03879J100</cusip>
        <identifiers>
          <isin value="CA03879J1003"/>
          <ticker value="ABUS"/>
        </identifiers>
        <balance>72962.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>316655.08000000</valUSD>
        <pctVal>0.682555427832</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>

        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>RELMADA THERAPEUTICS INC</name>
        <lei>549300217EASRZ9JSF81</lei>
        <title>RELMADA THERAPEUTICS INC COM</title>
        <cusip>75955J402</cusip>
        <identifiers>
          <isin value="US75955J4022"/>
          <ticker value="RLMD"/>
        </identifiers>
        <balance>46738.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>248178.78000000</valUSD>
        <pctVal>0.534953594812</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="248173.47000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BRIDGEBIO ONCOLOGY THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>BRIDGEBIO ONCOLOGY THERAPEUTICS INC COM NEW</title>
        <cusip>107924102</cusip>
        <identifiers>
          <isin value="US1079241022"/>
          <ticker value="BBOT"/>
        </identifiers>
        <balance>40107.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>324465.63000000</valUSD>
        <pctVal>0.699391201623</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>LB PHARMACEUTICALS INC</name>
        <lei>N/A</lei>
        <title>LB PHARMACEUTICALS INC COM SHS</title>
        <cusip>50180M108</cusip>
        <identifiers>
          <isin value="US50180M1080"/>
          <ticker value="LBRX"/>
        </identifiers>
        <balance>10936.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>438314.88000000</valUSD>
        <pctVal>0.944795202539</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VERA THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>VERA THERAPEUTICS INC CL A</title>
        <cusip>92337R101</cusip>
        <identifiers>
          <isin value="US92337R1014"/>
          <ticker value="VERA"/>
        </identifiers>
        <balance>9072.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>291211.20000000</valUSD>
        <pctVal>0.627710710358</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>TANGO THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>TANGO THERAPEUTICS INC COM</title>
        <cusip>87583X109</cusip>
        <identifiers>
          <isin value="US87583X1090"/>
          <ticker value="TNGX"/>
        </identifiers>
        <balance>10046.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>273050.28000000</valUSD>
        <pctVal>0.588564537430</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SPYGLASS PHARMA INC</name>
        <lei>N/A</lei>
        <title>SPYGLASS PHARMA INC COM SHS</title>
        <cusip>85220G109</cusip>
        <identifiers>
          <isin value="US85220G1094"/>
          <ticker value="SGP"/>
        </identifiers>
        <balance>16855.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>379743.15000000</valUSD>
        <pctVal>0.818542839150</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="82932.93000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MONOPAR THERAPEUTICS INC</name>
        <lei>549300QJFAI7L6YHKG83</lei>
        <title>MONOPAR THERAPEUTICS INC COM NEW</title>
        <cusip>61023L207</cusip>
        <identifiers>
          <isin value="US61023L2079"/>
          <ticker value="MNPR"/>
        </identifiers>
        <balance>5200.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>563420.00000000</valUSD>
        <pctVal>1.214461423291</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="476631.65000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>PROTHENA CORP PLC</name>
        <lei>5299009ZXQ8NIIJ8OL30</lei>
        <title>PROTHENA CORP PLC SHS</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="IE00B91XRN20"/>
          <ticker value="PRTA"/>
        </identifiers>
        <balance>37674.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>305912.88000000</valUSD>
        <pctVal>0.659400432444</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>RECURSION PHARMACEUTICALS INC</name>
        <lei>N/A</lei>
        <title>RECURSION PHARMACEUTICALS INC CL A</title>
        <cusip>75629V104</cusip>
        <identifiers>
          <isin value="US75629V1044"/>
          <ticker value="RXRX"/>
        </identifiers>
        <balance>98670.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>296010.00000000</valUSD>
        <pctVal>0.638054605637</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="291549.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>RAPPORT THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>RAPPORT THERAPEUTICS INC COM</title>
        <cusip>75383L102</cusip>
        <identifiers>
          <isin value="US75383L1026"/>
          <ticker value="RAPP"/>
        </identifiers>
        <balance>8094.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>331692.12000000</valUSD>
        <pctVal>0.714968024120</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>TYRA BIOSCIENCES INC</name>
        <lei>N/A</lei>
        <title>TYRA BIOSCIENCES INC COM</title>
        <cusip>90240B106</cusip>
        <identifiers>
          <isin value="US90240B1061"/>
          <ticker value="TYRA"/>
        </identifiers>
        <balance>11516.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>367130.08000000</valUSD>
        <pctVal>0.791355151556</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SELLAS LIFE SCIENCES GROUP INC</name>
        <lei>549300VZIH50VYURLQ98</lei>
        <title>SELLAS LIFE SCIENCES GROUP INC COM NEW</title>
        <cusip>81642T209</cusip>
        <identifiers>
          <isin value="US81642T2096"/>
          <ticker value="SLS"/>
        </identifiers>
        <balance>39695.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>397346.95000000</valUSD>
        <pctVal>0.856488130413</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="63853.79000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>UNIQURE NV</name>
        <lei>724500RPCTZLFYJZ3S98</lei>
        <title>UNIQURE NV SHS</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="NL0010696654"/>
          <ticker value="QURE"/>
        </identifiers>
        <balance>11273.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>491840.99000000</valUSD>
        <pctVal>1.060171645927</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CULLINAN THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>CULLINAN THERAPEUTICS INC COM</title>
        <cusip>230031106</cusip>
        <identifiers>
          <isin value="US2300311063"/>
          <ticker value="CGEM"/>
        </identifiers>
        <balance>22687.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>374335.50000000</valUSD>
        <pctVal>0.806886557308</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>LEXICON PHARMACEUTICALS INC</name>
        <lei>N/A</lei>
        <title>LEXICON PHARMACEUTICALS INC COM NEW</title>
        <cusip>528872302</cusip>
        <identifiers>
          <isin value="US5288723027"/>
          <ticker value="LXRX"/>
        </identifiers>
        <balance>161882.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>373947.42000000</valUSD>
        <pctVal>0.806050044246</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>WAVE LIFE SCIENCES LTD</name>
        <lei>54930070006GPKFYZ813</lei>
        <title>WAVE LIFE SCIENCES LTD SHS</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="SG9999014716"/>
          <ticker value="WVE"/>
        </identifiers>
        <balance>52951.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>291760.01000000</valUSD>
        <pctVal>0.628893679677</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>SG</invCountry>

        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MAZE THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>MAZE THERAPEUTICS INC COM</title>
        <cusip>578784100</cusip>
        <identifiers>
          <isin value="US5787841007"/>
          <ticker value="MAZE"/>
        </identifiers>
        <balance>12924.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>347914.08000000</valUSD>
        <pctVal>0.749934735685</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SIONNA THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>SIONNA THERAPEUTICS INC COM</title>
        <cusip>829401108</cusip>
        <identifiers>
          <isin value="US8294011080"/>
          <ticker value="SION"/>
        </identifiers>
        <balance>8653.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>407815.89000000</valUSD>
        <pctVal>0.879054109208</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>JANUX THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>JANUX THERAPEUTICS INC COM</title>
        <cusip>47103J105</cusip>
        <identifiers>
          <isin value="US47103J1051"/>
          <ticker value="JANX"/>
        </identifiers>
        <balance>22923.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>347741.91000000</valUSD>
        <pctVal>0.749563620312</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>PHARVARIS NV</name>
        <lei>9845003BE146D3B75D32</lei>
        <title>PHARVARIS NV COM</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="NL00150005Y4"/>
          <ticker value="PHVS"/>
        </identifiers>
        <balance>10118.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>330049.16000000</valUSD>
        <pctVal>0.711426595807</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CORVUS PHARMACEUTICALS INC</name>
        <lei>549300I3AVJ8F75NCX65</lei>
        <title>CORVUS PHARMACEUTICALS INC COM</title>
        <cusip>221015100</cusip>
        <identifiers>
          <isin value="US2210151005"/>
          <ticker value="CRVS"/>
        </identifiers>
        <balance>26054.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>345476.04000000</valUSD>
        <pctVal>0.744679498866</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>XENCOR INC</name>
        <lei>549300V5IF65437JKG30</lei>
        <title>XENCOR INC COM</title>
        <cusip>98401F105</cusip>
        <identifiers>
          <isin value="US98401F1057"/>
          <ticker value="XNCR"/>
        </identifiers>
        <balance>25208.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>509453.68000000</valUSD>
        <pctVal>1.098136099737</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="509433.47000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ROCKET PHARMACEUTICALS INC</name>
        <lei>549300R7VV82YUIN4Y93</lei>
        <title>ROCKET PHARMACEUTICALS INC COM</title>
        <cusip>77313F106</cusip>
        <identifiers>
          <isin value="US77313F1066"/>
          <ticker value="RCKT"/>
        </identifiers>
        <balance>113024.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>351504.64000000</valUSD>
        <pctVal>0.757674249029</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="245677.56000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MEIRAGTX HOLDINGS PLC</name>
        <lei>54930007YV6NYIOGFZ57</lei>
        <title>MEIRAGTX HOLDINGS PLC COM</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="KYG596651029"/>
          <ticker value="MGTX"/>
        </identifiers>
        <balance>32410.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>382113.90000000</valUSD>
        <pctVal>0.823653031226</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ATAIBECKLEY INC</name>
        <lei>529900HOVZ0MXOBQ5Y47</lei>
        <title>ATAIBECKLEY INC COM SHS</title>
        <cusip>04650F101</cusip>
        <identifiers>
          <isin value="US04650F1012"/>
          <ticker value="ATAI"/>
        </identifiers>
        <balance>79289.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>569295.02000000</valUSD>
        <pctVal>1.227125129143</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>DESIGN THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>DESIGN THERAPEUTICS INC COM</title>
        <cusip>25056L103</cusip>
        <identifiers>
          <isin value="US25056L1035"/>
          <ticker value="DSGN"/>
        </identifiers>
        <balance>28333.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>345095.94000000</valUSD>
        <pctVal>0.743860186831</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ASSEMBLY BIOSCIENCES INC</name>
        <lei>5299007Y1X8RBDFT8C40</lei>
        <title>ASSEMBLY BIOSCIENCES INC COM NEW</title>
        <cusip>045396207</cusip>
        <identifiers>
          <isin value="US0453962070"/>
          <ticker value="ASMB"/>
        </identifiers>
        <balance>13537.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>339914.07000000</valUSD>
        <pctVal>0.732690577631</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="10044.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>GH RESEARCH PLC</name>
        <lei>875500HKJS7QQG6EWH62</lei>
        <title>GH RESEARCH PLC ORDINARY SHARES</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="IE000GID8VI0"/>
          <ticker value="GHRS"/>
        </identifiers>
        <balance>14716.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>413078.12000000</valUSD>
        <pctVal>0.890396935759</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="253640.52000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ARVINAS INC</name>
        <lei>N/A</lei>
        <title>ARVINAS INC COM</title>
        <cusip>04335A105</cusip>
        <identifiers>
          <isin value="US04335A1051"/>
          <ticker value="ARVN"/>
        </identifiers>
        <balance>41004.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>329262.12000000</valUSD>
        <pctVal>0.709730117658</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ERASCA INC</name>
        <lei>N/A</lei>
        <title>ERASCA INC COM</title>
        <cusip>29479A108</cusip>
        <identifiers>
          <isin value="US29479A1088"/>
          <ticker value="ERAS"/>
        </identifiers>
        <balance>22122.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>401514.30000000</valUSD>
        <pctVal>0.865470924443</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BELITE BIO INC</name>
        <lei>984500BD54036BOEAE79</lei>
        <title>BELITE BIO INC SPONSORED ADS</title>
        <cusip>07782B104</cusip>
        <identifiers>
          <isin value="US07782B1044"/>
          <ticker value="BLTE"/>
        </identifiers>
        <balance>2250.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>356872.50000000</valUSD>
        <pctVal>0.769244762847</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ALTIMMUNE INC</name>
        <lei>549300EOYCQ8SW3NVE64</lei>
        <title>ALTIMMUNE INC COM NEW</title>
        <cusip>02155H200</cusip>
        <identifiers>
          <isin value="US02155H2004"/>
          <ticker value="ALT"/>
        </identifiers>
        <balance>119086.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>338204.24000000</valUSD>
        <pctVal>0.729005009892</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>4D MOLECULAR THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>4D MOLECULAR THERAPEUTICS INC COM</title>
        <cusip>35104E100</cusip>
        <identifiers>
          <isin value="US35104E1001"/>
          <ticker value="FDMT"/>
        </identifiers>
        <balance>35199.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>358325.82000000</valUSD>
        <pctVal>0.772377418904</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="342475.56000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SUMMIT THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>SUMMIT THERAPEUTICS INC COM</title>
        <cusip>86627T108</cusip>
        <identifiers>
          <isin value="US86627T1088"/>
          <ticker value="SMMT"/>
        </identifiers>
        <balance>22185.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>288848.70000000</valUSD>
        <pctVal>0.622618301298</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="288835.68000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MOONLAKE IMMUNOTHERAPEUTICS</name>
        <lei>N/A</lei>
        <title>MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD</title>
        <cusip>61559X104</cusip>
        <identifiers>
          <isin value="KY61559X1045"/>
          <ticker value="MLTX"/>
        </identifiers>
        <balance>16630.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>306657.20000000</valUSD>
        <pctVal>0.661004826904</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CG ONCOLOGY INC</name>
        <lei>N/A</lei>
        <title>CG ONCOLOGY INC COM</title>
        <cusip>156944100</cusip>
        <identifiers>
          <isin value="US1569441009"/>
          <ticker value="CGON"/>
        </identifiers>
        <balance>5218.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>371469.42000000</valUSD>
        <pctVal>0.800708672965</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>INHIBRX BIOSCIENCES INC</name>
        <lei>N/A</lei>
        <title>INHIBRX BIOSCIENCES INC COM</title>
        <cusip>45720N103</cusip>
        <identifiers>
          <isin value="US45720N1037"/>
          <ticker value="INBX"/>
        </identifiers>
        <balance>3371.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>276590.55000000</valUSD>
        <pctVal>0.596195649820</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>DAMORA THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>DAMORA THERAPEUTICS INC COM USD0.00001</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="KYG2646Y1044"/>
          <ticker value="DMRA"/>
        </identifiers>
        <balance>14957.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>433603.43000000</valUSD>
        <pctVal>0.934639591675</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>XENON PHARMACEUTICALS INC</name>
        <lei>549300XV44Q9Z1MIPQ03</lei>
        <title>XENON PHARMACEUTICALS INC COM</title>
        <cusip>98420N105</cusip>
        <identifiers>
          <isin value="CA98420N1050"/>
          <ticker value="XENE"/>
        </identifiers>
        <balance>5966.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>373889.22000000</valUSD>
        <pctVal>0.805924593153</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>IDEAYA BIOSCIENCES INC</name>
        <lei>549300ULW08F62IJML11</lei>
        <title>IDEAYA BIOSCIENCES INC COM</title>
        <cusip>45166A102</cusip>
        <identifiers>
          <isin value="US45166A1025"/>
          <ticker value="IDYA"/>
        </identifiers>
        <balance>10725.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>380737.50000000</valUSD>
        <pctVal>0.820686177541</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>COGENT BIOSCIENCES INC</name>
        <lei>N/A</lei>
        <title>COGENT BIOSCIENCES INC COM</title>
        <cusip>19240Q201</cusip>
        <identifiers>
          <isin value="US19240Q2012"/>
          <ticker value="COGT"/>
        </identifiers>
        <balance>9390.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>365552.70000000</valUSD>
        <pctVal>0.787955082052</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>OLEMA PHARMACEUTICALS INC</name>
        <lei>N/A</lei>
        <title>OLEMA PHARMACEUTICALS INC COM</title>
        <cusip>68062P106</cusip>
        <identifiers>
          <isin value="US68062P1066"/>
          <ticker value="OLMA"/>
        </identifiers>
        <balance>31490.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>360560.50000000</valUSD>
        <pctVal>0.777194309773</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CRESCENT BIOPHARMA INC</name>
        <lei>N/A</lei>
        <title>CRESCENT BIOPHARMA INC COM USD0.001</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="KYG2545C1042"/>
          <ticker value="CBIO"/>
        </identifiers>
        <balance>17344.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>250967.68000000</valUSD>
        <pctVal>0.540965116348</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>REZOLUTE INC</name>
        <lei>549300T05L48T72P2G08</lei>
        <title>REZOLUTE INC COM NEW</title>
        <cusip>76200L309</cusip>
        <identifiers>
          <isin value="US76200L3096"/>
          <ticker value="RZLT"/>
        </identifiers>
        <balance>77705.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>366767.60000000</valUSD>
        <pctVal>0.790573819731</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="366762.88000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>OCULIS HOLDING AG</name>
        <lei>5067005370C2KK324336</lei>
        <title>OCULIS HOLDING AG ORDINARY SHARES</title>
        <cusip>000000000</cusip>
        <identifiers>
          <isin value="CH1242303498"/>
          <ticker value="OCS"/>
        </identifiers>
        <balance>28027.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>316985.37000000</valUSD>
        <pctVal>0.683267373562</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CH</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SEPTERNA INC</name>
        <lei>N/A</lei>
        <title>SEPTERNA INC COM</title>
        <cusip>81734D104</cusip>
        <identifiers>
          <isin value="US81734D1046"/>
          <ticker value="SEPN"/>
        </identifiers>
        <balance>8646.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>297854.70000000</valUSD>
        <pctVal>0.642030887962</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>RELAY THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>RELAY THERAPEUTICS INC COM</title>
        <cusip>75943R102</cusip>
        <identifiers>
          <isin value="US75943R1023"/>
          <ticker value="RLAY"/>
        </identifiers>
        <balance>20989.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>395222.87000000</valUSD>
        <pctVal>0.851909639731</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CYTOMX THERAPEUTICS INC</name>
        <lei>5493004VW2FW0QLL3345</lei>
        <title>CYTOMX THERAPEUTICS INC COM</title>
        <cusip>23284F105</cusip>
        <identifiers>
          <isin value="US23284F1057"/>
          <ticker value="CTMX"/>
        </identifiers>
        <balance>103259.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>320102.90000000</valUSD>
        <pctVal>0.689987262670</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AMYLYX PHARMACEUTICALS INC</name>
        <lei>N/A</lei>
        <title>AMYLYX PHARMACEUTICALS INC COM</title>
        <cusip>03237H101</cusip>
        <identifiers>
          <isin value="US03237H1014"/>
          <ticker value="AMLX"/>
        </identifiers>
        <balance>21303.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>432663.93000000</valUSD>
        <pctVal>0.932614483395</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AURA BIOSCIENCES INC</name>
        <lei>N/A</lei>
        <title>AURA BIOSCIENCES INC COM</title>
        <cusip>05153U107</cusip>
        <identifiers>
          <isin value="US05153U1079"/>
          <ticker value="AURA"/>
        </identifiers>
        <balance>48490.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>339914.90000000</valUSD>
        <pctVal>0.732692366710</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>NEKTAR THERAPEUTICS</name>
        <lei>5299005I24806IOIYE03</lei>
        <title>NEKTAR THERAPEUTICS COM NEW</title>
        <cusip>640268306</cusip>
        <identifiers>
          <isin value="US6402683063"/>
          <ticker value="NKTR"/>
        </identifiers>
        <balance>5234.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>369886.78000000</valUSD>
        <pctVal>0.797297265442</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>NEUROGENE INC</name>
        <lei>529900A7VIY892SZVW73</lei>
        <title>NEUROGENE INC COM</title>
        <cusip>64135M105</cusip>
        <identifiers>
          <isin value="US64135M1053"/>
          <ticker value="NGNE"/>
        </identifiers>
        <balance>10681.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>351298.09000000</valUSD>
        <pctVal>0.757229026979</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CABALETTA BIO INC</name>
        <lei>N/A</lei>
        <title>CABALETTA BIO INC COM</title>
        <cusip>12674W109</cusip>
        <identifiers>
          <isin value="US12674W1099"/>
          <ticker value="CABA"/>
        </identifiers>
        <balance>103259.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>276734.12000000</valUSD>
        <pctVal>0.596505117405</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>PALVELLA THERAPEUTICS INC</name>
        <lei>254900AJDH8PAOOI5T33</lei>
        <title>PALVELLA THERAPEUTICS INC COM</title>
        <cusip>697947109</cusip>
        <identifiers>
          <isin value="US6979471090"/>
          <ticker value="PVLA"/>
        </identifiers>
        <balance>2856.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>397098.24000000</valUSD>
        <pctVal>0.855952031764</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VIRIDIAN THERAPEUTICS INC</name>
        <lei>549300C775BNYF550E70</lei>
        <title>VIRIDIAN THERAPEUTICS INC COM</title>
        <cusip>92790C104</cusip>
        <identifiers>
          <isin value="US92790C1045"/>
          <ticker value="VRDN"/>
        </identifiers>
        <balance>19010.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>359669.20000000</valUSD>
        <pctVal>0.775273097415</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>DIANTHUS THERAPEUTICS INC</name>
        <lei>549300Z3N6ODPCOFC890</lei>
        <title>DIANTHUS THERAPEUTICS INC COM</title>
        <cusip>252828108</cusip>
        <identifiers>
          <isin value="US2528281080"/>
          <ticker value="DNTH"/>
        </identifiers>
        <balance>3787.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>404906.04000000</valUSD>
        <pctVal>0.872781877884</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="404799.12000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VIKING THERAPEUTICS INC</name>
        <lei>529900IVC72YPFA25M37</lei>
        <title>VIKING THERAPEUTICS INC COM</title>
        <cusip>92686J106</cusip>
        <identifiers>
          <isin value="US92686J1060"/>
          <ticker value="VKTX"/>
        </identifiers>
        <balance>10811.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>343141.14000000</valUSD>
        <pctVal>0.739646582077</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="343109.40000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>DEFINIUM THERAPEUTICS INC</name>
        <lei>549300QY8KN1O6RPFJ13</lei>
        <title>DEFINIUM THERAPEUTICS INC COM SHS</title>
        <cusip>24477V105</cusip>
        <identifiers>
          <isin value="CA24477V1058"/>
          <ticker value="DFTX"/>
        </identifiers>
        <balance>12558.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>546524.16000000</valUSD>
        <pctVal>1.178042151887</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>

        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>NURIX THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>NURIX THERAPEUTICS INC COM</title>
        <cusip>67080M103</cusip>
        <identifiers>
          <isin value="US67080M1036"/>
          <ticker value="NRIX"/>
        </identifiers>
        <balance>18337.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>425601.77000000</valUSD>
        <pctVal>0.917391877018</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>REGENXBIO INC</name>
        <lei>549300EOES47LATSET33</lei>
        <title>REGENXBIO INC COM</title>
        <cusip>75901B107</cusip>
        <identifiers>
          <isin value="US75901B1070"/>
          <ticker value="RGNX"/>
        </identifiers>
        <balance>46670.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>452232.30000000</valUSD>
        <pctVal>0.974794438813</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SCHOLAR ROCK HOLDING CORP</name>
        <lei>549300Z1FLPGL4OWJ459</lei>
        <title>SCHOLAR ROCK HOLDING CORP COM</title>
        <cusip>80706P103</cusip>
        <identifiers>
          <isin value="US80706P1030"/>
          <ticker value="SRRK"/>
        </identifiers>
        <balance>7035.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>332720.33000000</valUSD>
        <pctVal>0.717184348318</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="332673.03703400"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CAPRICOR THERAPEUTICS INC</name>
        <lei>5493002ZI5PDLXV4DX14</lei>
        <title>CAPRICOR THERAPEUTICS INC COM NEW</title>
        <cusip>14070B309</cusip>
        <identifiers>
          <isin value="US14070B3096"/>
          <ticker value="CAPR"/>
        </identifiers>
        <balance>12047.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>46380.95000000</valUSD>
        <pctVal>0.099974929094</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SOLID BIOSCIENCES INC</name>
        <lei>N/A</lei>
        <title>SOLID BIOSCIENCES INC COM NEW</title>
        <cusip>83422E204</cusip>
        <identifiers>
          <isin value="US83422E2046"/>
          <ticker value="SLDB"/>
        </identifiers>
        <balance>43531.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>350859.86000000</valUSD>
        <pctVal>0.756284414737</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MINERALYS THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>MINERALYS THERAPEUTICS INC COM</title>
        <cusip>603170101</cusip>
        <identifiers>
          <isin value="US6031701013"/>
          <ticker value="MLYS"/>
        </identifiers>
        <balance>13159.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>335817.68000000</valUSD>
        <pctVal>0.723860739092</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ALTO NEUROSCIENCE INC</name>
        <lei>N/A</lei>
        <title>ALTO NEUROSCIENCE INC COM SHS</title>
        <cusip>02157Q109</cusip>
        <identifiers>
          <isin value="US02157Q1094"/>
          <ticker value="ANRO"/>
        </identifiers>
        <balance>14476.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>391865.32000000</valUSD>
        <pctVal>0.844672383418</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>COMPASS PATHWAYS PLC</name>
        <lei>213800N7CUZIC6QSTZ31</lei>
        <title>COMPASS PATHWAYS PLC SPONSORED ADS</title>
        <cusip>20451W101</cusip>
        <identifiers>
          <isin value="US20451W1018"/>
          <ticker value="CMPS"/>
        </identifiers>
        <balance>25731.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>292046.85000000</valUSD>
        <pctVal>0.629511968192</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CELLDEX THERAPEUTICS INC</name>
        <lei>529900F018DMYWH38923</lei>
        <title>CELLDEX THERAPEUTICS INC COM NEW</title>
        <cusip>15117B202</cusip>
        <identifiers>
          <isin value="US15117B2025"/>
          <ticker value="CLDX"/>
        </identifiers>
        <balance>9940.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>378316.40000000</valUSD>
        <pctVal>0.815467455181</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>LEXEO THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>LEXEO THERAPEUTICS INC COM</title>
        <cusip>52886X107</cusip>
        <identifiers>
          <isin value="US52886X1072"/>
          <ticker value="LXEO"/>
        </identifiers>
        <balance>71124.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>293742.12000000</valUSD>
        <pctVal>0.633166151602</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SPYRE THERAPEUTICS INC</name>
        <lei>52990017AIJPRH3HQH40</lei>
        <title>SPYRE THERAPEUTICS INC COM NEW</title>
        <cusip>00773J202</cusip>
        <identifiers>
          <isin value="US00773J2024"/>
          <ticker value="SYRE"/>
        </identifiers>
        <balance>3847.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>378275.51000000</valUSD>
        <pctVal>0.815379316089</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CANDEL THERAPEUTICS INC</name>
        <lei>N/A</lei>
        <title>CANDEL THERAPEUTICS INC COM</title>
        <cusip>137404109</cusip>
        <identifiers>
          <isin value="US1374041093"/>
          <ticker value="CADL"/>
        </identifiers>
        <balance>36310.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>363463.10000000</valUSD>
        <pctVal>0.783450913598</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1141.14000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>TAYSHA GENE THERAPIES INC</name>
        <lei>N/A</lei>
        <title>TAYSHA GENE THERAPIES INC COM SHS</title>
        <cusip>877619106</cusip>
        <identifiers>
          <isin value="US8776191061"/>
          <ticker value="TSHA"/>
        </identifiers>
        <balance>54433.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>318977.38000000</valUSD>
        <pctVal>0.687561185106</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="318971.52000000"/>
        </securityLending>
      </invstOrSec>
    </invstOrSecs>
    <signature>
      <ncom:dateSigned>2026-09-29</ncom:dateSigned>
      <ncom:nameOfApplicant>ETFis Series Trust I</ncom:nameOfApplicant>
      <ncom:signature>Brinton W. Frith</ncom:signature>
      <ncom:signerName>Brinton W. Frith</ncom:signerName>
      <ncom:title>Treasurer and Principal Financial Officer</ncom:title>
    </signature>
  </formData>
  <documents>XXXX</documents>
</edgarSubmission>
